2025-521069-28-00已完成4 期
Randomised, crossover bioequivalence clinical trial of escitalopram 20 mg capsules versus escitalopram 20 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions
Alter Farmacia S.A.1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2025年3月4日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Carmen Morillo Alonso
Scientific
Alter Farmacia S.A.
研究点 (1)
Loading locations...
相似试验
招募中
4 期
Randomised, crossover bioequivalence clinical trial of edoxaban 60 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.2022-502085-24-00Biohorm S.L.15
招募中
4 期
Randomised, crossover bioequivalence clinical trial of memantine 20 mg capsules versus memantine 20 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.2025-523808-75-00Laboratorios Alter S.A.24
已完成
4 期
Randomised, crossover bioequivalence clinical trial of linagliptin/metformin 2.5 mg/1000 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fed conditions.diabetes2024-512310-18-00Laboratorios Alter S.A.36
已完成
4 期
Randomised, crossover bioequivalence clinical trial of montelukast 10 mg capsules vs montelukast 10 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.Asthma2023-506937-30-00Laboratorios Alter S.A.36
招募中
4 期
Randomised, crossover bioequivalence clinical trial of edoxaban 60 mg tablets versus edoxaban 60 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.2025-522225-35-00Laboratorios Alter S.A.30